Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Sinochem Holdings Corp Ltd | 554 |
| 2 | Bayer AG | 200 |
| 3 | Corteva Inc | 186 |
| 4 | Ishihara Sangyo Kaisha Ltd | 129 |
| 5 | FMC Corp | 119 |
| 6 | Agency for Science, Technology and Research | 39 |
| 7 | Nippon Sheet Glass Co Ltd | 33 |
| 8 | The University of Texas System | 33 |
| 9 | Texas A&M University System | 31 |
| 10 | BioNTech SE | 17 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A01N | Preservation of bodies; biocides; pest repellents | 1,467 |
| 2 | C07D | Heterocyclic compounds | 1,064 |
| 3 | C07C | Acyclic and carbocyclic compounds | 246 |
| 4 | A61K | Medicinal preparations | 241 |
| 5 | A61P | Therapeutic activity (drug indications) | 225 |
| 6 | C12N | Microorganisms, enzymes | 214 |
| 7 | G01N | Investigating / analysing materials | 187 |
| 8 | C12Q | Measuring/testing involving enzymes | 114 |
| 9 | C07F | Organometallic compounds | 101 |
| 10 | A61L | Sterilising / disinfecting materials | 78 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee |
|---|---|---|
| Dimethylarsinous acid-induced malignantly transformed cell line of human keratinocytes and use thereof | 2025 | |
| Preparation method of porous magnetic composite adsorbent and application of porous magnetic composite adsorbent in adsorption of dimethylarsinic acid | 2022 | |
| TRIVALENT DIMETHYLARSINOUS ACID INDUCED HUMAN KERATINOCYTE MALIGNANT TRANSFORMATION CELL STRAIN, AND USE THEREOF | 2022 | |
| Human keratinocyte malignant transformation cell strain caused by dimethylarsinic acid and application thereof | 2021 | |
| Human keratinocyte malignant transformation cell strain caused by dimethylarsinic acid and application thereof | 2021 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Hua Naranmandura | Zhejiang University | 14 |
| 2 | X. Chris Le | University of Alberta | 14 |
| 3 | Lora L. Arnold | University of Nebraska Medical Center | 10 |
| 4 | Samuel M. Cohen | University of Nebraska Medical Center | 9 |
| 5 | Miroslav Stýblo | University of North Carolina at Chapel Hill | 8 |
| 6 | Walter Cullen | University of British Columbia | 6 |
| 7 | Xiufen Lu | University of Alberta | 6 |
| 8 | Noriyuki Suzuki | Chiba University | 5 |
| 9 | Kanwal Rehman | Zhejiang University | 5 |
| 10 | Dinoraz Vélez | Instituto de Agroquímica y Tecnología de Alimentos | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| DNA Damage Induced by Methylated Trivalent Arsenicals Is Mediated by Reactive Oxygen Species | 2002 | 252 | Carcinogens and Genotoxicity Assessment |
| Exposure to arsenic in drinking water is associated with increased prevalence of diabetes: a cross-sectional study in the Zimapán and Lagunera regions in Mexico | 2011 | 236 | Arsenic contamination and mitigation |
| Trivalent Arsenicals Are Bound to Proteins during Reductive Methylation | 2006 | 225 | Arsenic contamination and mitigation |
| Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing | 2016 | 179 | Arsenic contamination and mitigation |
| Evidence of Hemoglobin Binding to Arsenic as a Basis for the Accumulation of Arsenic in Rat Blood | 2004 | 166 | Arsenic contamination and mitigation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of dimethylarsinous acid?
Which organizations hold the most patents involving dimethylarsinous acid?
What are the primary research topics associated with dimethylarsinous acid in the scientific literature?
Who are the leading researchers publishing on dimethylarsinous acid?
What is the trend in patent and publication activity for dimethylarsinous acid?